Ranbaxy Lab gearing up to introduce anti-ulcer drug in US by December
-
30/07/1998
-
Financial Express (New Delhi)
The Rs 1,333 crore Ranbaxy Laboratories is readying itself to launch a 75 mg over the counter version (OTC) of anti-ulcer drug, rantidine, in the US by Decemeber this year to cash in on the generic wave.